Juvéderm Voluma is the newest HA (hyaluronic acid) soft tissue filler to gain FDA approval. It has been available in Europe since 2005 and is used in 72 countries worldwide. Juvéderm Voluma is the newest filler in the family of Juvéderm products, and is formulated with lidocaine for added comfort during treatment. This current form, with the added local anesthetic, is known as Juvéderm Voluma XC.
Dr. Johnson has long been Oklahoma’s most experienced cosmetic injection physician and works with each of her patients to find the best filler to best fit special needs.
What makes JUVEDERM VOLUMA different?
The loss of midface volume is one of the hallmarks of facial aging. This occurs in varying degrees of severity, and can lead to significant changes in the facial appearance. One of the most noticeable changes is the loss of cheekbone definition. Historically, this was addressed with aggressive plastic surgery to tighten the overlying skin and lift the deeper soft tissues. More recently, volumizing fillers have been used to provide a similar ‘lift’ without surgery. The goal is to restore volume in the midface to create a natural, youthful face.
Juvéderm Voluma is the first filler formulated with lidocaine that is FDA approved to restore age-related volume changes in the cheeks and lesson procedure sensitivity. Unlike other fillers commonly used to treat the midface, Voluma is a hyaluronic acid (HA) filler. HA fillers are made from long chains of sugars that occur naturally in the skin. Juvéderm Voluma is unique in that the HA is cross-linked through a process called Vycross that helps provide an excellent lifting capacity. And since it is an HA filler, it can be molded and shaped into the desired contour after injection.